VSP Global Announces the Promotion of Nicola Zotta as Marchon’s President

By Staff
Wednesday, May 25, 2016 9:00 AM RANCHO CORDOVA, Calif.—VSP Global has announced the appointment of Nicola Zotta as president of Marchon Eyewear, effective June 1, 2016, following the retirement of Claudio Gottardi.

Ora Names David A. Hollander, MD, MBA, as Chief Medical Officer and SVP

By Staff
Monday, May 16, 2016 12:21 AM BOSTON, Mass.—Ora, Inc., a leading partner for ophthalmic pharmaceutical and device development, has appointed David A. Hollander, MD, MBA, as chief medical officer and senior vice president.

People

By Staff
Monday, May 16, 2016 12:00 AM RANCHO CORDOVA, Calif.—The VSP Global board of directors named Daniel L. Mannen, OD, FAAO, as chairman of the board for a two-year term. Dr. Mannen is the first-ever returning chairman of the board, having served a two-year term previously from 2006 to 2008.

Allergan Streamlines Executive Team in Business Realignment

By Staff
Friday, May 13, 2016 12:27 AM DUBLIN—During Allergan’s (NYSE: AGN) conference call with investors earlier this week, Brent Saunders, the company’s president and CEO, announced “a streamlined executive team to lead Allergan going forward.”

VSP Global Names 2016 Chairman of the Board

By Staff
Monday, May 2, 2016 12:30 AM RANCHO CORDOVA, Calif.—The VSP Global board of directors named Daniel L. Mannen, OD, FAAO, as chairman of the board for a two-year term.

Valeant Announces Nominees for Election to Board of Directors; Seven Current Directors to Exit Board

By Staff
Monday, May 2, 2016 12:21 AM LAVAL, Quebec—Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced the nominees for election to its board of directors at the 2016 Annual Meeting of Shareholders scheduled for June 14, 2016.

New CEO at Silhouette International

By Staff
Friday, April 29, 2016 12:27 AM LINZ, Austria—Jan Rosenberg is the new CEO of Silhouette International. He is now managing the family-owned company, together with Thomas Windischbauer, COO/CFO, the company said in an announcement.

Valeant Names Joseph C. Papa Chairman and CEO of Valeant

By Staff
Monday, April 25, 2016 11:30 AM LAVAL, Quebec—Valeant Pharmaceuticals International, Inc. announced that its board of directors has named Joseph C. Papa to become Valeant's new chairman and CEO, succeeding J. Michael Pearson.

Jeff Hopkins Joins GSRx as Marketing Director

By Staff
Monday, April 25, 2016 12:27 AM SCOTTSDALE, Ariz.—GSRx, Inc., an independent wholesale lab located here, has appointed industry veteran Jeff Hopkins as marketing director.

Coburn Technologies Names Brandie Shaw as National Sales Manager

By Staff
Friday, April 15, 2016 12:15 AM SOUTH WINDSOR, Conn.—Coburn Technologies has appointed industry veteran Brandie Shaw as its new national sales manager.

Vuarnet Names Chad Smith Rx Sales Development Director

By Staff
Wednesday, April 13, 2016 12:24 AM NEW YORK—Vuarnet announced that Chad Smith has been appointed to the position of Rx sales development director.

Colors in Optics, Ltd. Appoints Felix Marks Director of Sales and Marketing

By Staff
Wednesday, April 13, 2016 12:21 AM NEW YORK—Colors in Optics, Ltd. announced that Felix Marks joined the company as director of sales and marketing.

Holly Rush Appointed New CEO of Costa Del Mar

By Staff
Monday, April 4, 2016 12:30 PM DAYTONA BEACH, Fla.—Costa Del Mar, the U.S.-based sun brand and a leading manufacturer of the polarized performance sunglasses, announced today the appointment of Holly Rush to the position of CEO, effective April 25, 2016.

Second Sight Appoints Steven D. Okland Jr. Commercial Vice President

By Staff
Monday, March 28, 2016 12:24 AM SYLMAR, CALIF.—Second Sight Medical Products Inc., a developer, manufacturer and marketer of implantable visual prosthetics that provide vision to blind patients, named Steven D. Okland Jr. as commercial vice president, U.S. and Canada, according to an announcement from the company.

Valeant Initiates Search for New CEO, Adds Pershing’s Ackman to Board

By Staff
Wednesday, March 23, 2016 12:18 AM LAVAL, Quebec— Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that it has initiated a search for a new chief executive officer, appointed William A. Ackman to its board of directors and provided an update on certain accounting and financial reporting matters.
Loading...